Amikacin Liposomal Inhalation Suspension for Non-Tuberculous <i>Mycobacteria</i> Lung Infection: A Greek Observational Study

<i>Background and Objectives:</i> Intravenous amikacin, recommended for severe or recurrent <i>M. avium complex</i> (MAC) infections and as initial treatment for <i>M. abscessus</i> lung disease, is often limited by serious adverse effects such as renal and audito...

Full description

Bibliographic Details
Published in:Medicina
Main Authors: Angeliki A. Loukeri, Evgenia Papathanassiou, Aikaterini Kavvada, Christos F. Kampolis, Ioannis Pantazopoulos, Charalambos Moschos, Apostolos Papavasileiou
Format: Article
Language:English
Published: MDPI AG 2024-10-01
Subjects:
Online Access:https://www.mdpi.com/1648-9144/60/10/1620